Key facts
- This page summarizes Ryan Lada's Form 4 filing for AZEK Co Inc. (AZEK).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2025, 06:30.
Ryan Lada - 01 Jul 2025 Form 4 Insider Report for AZEK Co Inc. (AZEK)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- AZEK
- Reported as of
- 01 Jul 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2025, 06:30:30 UTC
- Prior SEC filing
- 10 Feb 2025
- Next SEC filing
- 28 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Morgan Walbridge, as Attorney-in-Fact for Ryan Lada
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ryan Lada filed Form 4 for AZEK Co Inc. (AZEK) on 02 Jul 2025.
Change
- Previous filing in this sequence was filed on 10 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002052605
Primary reporting owner
Lada Ryan
- Relationship
- Chief Financial Officer
- Address
- 1330 W. FULTON ST., SUITE 350, CHICAGO
- Signature
- /s/ Morgan Walbridge, as Attorney-in-Fact for Ryan Lada
- Signature date
- 02 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AZEK
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -21,656
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AZEK
transaction
Derivative
Performance-Based Restricted Stock Units
Disposed to Issuer
- Transaction value
- Shares
- -17,458
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,458
- Exercise price
- Footnotes
- F1, F4, F5
AZEK
transaction
Derivative
Non-qualified stock options (right-to-buy)
Disposed to Issuer
- Transaction value
- Shares
- -3,758
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,758
- Exercise price
- $50.09
- Footnotes
- F1, F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Ryan Lada is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 7 footnotes
Footnote F1
Represents shares (including in respect of shares underlying, as applicable, Company RSU Awards, Company PSU Awards and Company Stock Options (each as defined in the Agreement and Plan of Merger, dated as of March 23, 2025 (as amended, the "Merger Agreement"), by and among The AZEK Company Inc. ("AZEK"), James Hardie Industries plc ("JHX") and Juno Merger Sub Inc.)) disposed of pursuant to the closing of the transactions contemplated by the Merger Agreement.
Footnote F2
In accordance with the Merger Agreement, upon the Effective Time (as defined in the Merger Agreement), each share of Company Common Stock (as defined in the Merger Agreement) that was issued and outstanding immediately prior to the Effective Time (subject to certain exceptions) was converted into the right to receive $26.45 in cash, without interest (the "Cash Consideration"), and 1.0340 (the "Exchange Ratio") JHX ordinary shares, with cash in lieu of fractional JHX ordinary shares, where any such aggregated fractional shares are rounded to four (4) decimal places and multiplied by JHX's five-trading day volume-weighted average price ending on June 30, 2025, the trading day immediately prior to the closing of the transactions contemplated by the Merger Agreement (the "Parent Share Price") (collectively, the "Merger Consideration"). The Parent Share Price was $26.053018.
Footnote F3
Upon the Effective Time, each then-outstanding Company RSU Award held by the reporting person was assumed by JHX and converted into (A) a time-based restricted stock unit award of JHX covering a number of JHX ordinary shares (rounded to the nearest whole number of shares) equal to the product obtained by multiplying (1) the number of shares of Company Common Stock (as defined in the Merger Agreement) subject to the Company RSU Award by (2) the Exchange Ratio and (B) a cash award having a value equal to the product obtained by multiplying (1) the number of shares of Company Common Stock subject to the Company RSU Award by (2) the Cash Consideration. Each time-based restricted stock unit award of JHX and each cash award is subject to the same terms and conditions as were applicable to the Company RSU Award immediately prior to the Effective Time, including the vesting schedule.
Footnote F4
Upon the Effective Time, each then-outstanding Company PSU Award was assumed by JHX and converted into (A) a time-based restricted stock unit award of JHX covering a number of JHX ordinary shares (rounded to the nearest whole number of shares) equal to the product obtained by multiplying (1) the number of shares of Company Common Stock subject to the Company PSU Award by (2) the Exchange Ratio and (B) a cash award having a value equal to the product obtained by multiplying (1) the number of shares of Company Common Stock subject to the Company PSU Award by (2) the Cash Consideration. For purposes of the foregoing calculations, the number of shares of Company Common Stock subject to the Company PSU Award was determined based on (i) for fiscal years 2024 and 2025, actual performance and (ii) for fiscal years 2026 and 2027, target performance.
Footnote F5
(Continued from footnote 4) Each time-based restricted stock unit award of JHX and each cash award is subject to the same terms and conditions as were applicable to such Company PSU Award immediately prior to the Effective Time, including the vesting schedule (except that the performance-based vesting conditions do not apply from and after the Effective Time).
Footnote F6
Upon the Effective Time, each then-outstanding Company Stock Option held by the reporting person was assumed by JHX and converted into an option to purchase a number of JHX ordinary shares (rounded down to the nearest whole number of shares) equal to the product of (A) the number of shares of Company Common Stock subject to such Company Stock Option multiplied by (B) the Equity Award Exchange Ratio, with an exercise price per JHX ordinary share equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (A) the exercise price per share of Company Common Stock subject to such Company Stock Option by (B) the Equity Award Exchange Ratio. The Equity Award Exchange Ratio is defined as the sum of (A) the quotient (rounded to four (4) decimal places) obtained by dividing (x) the Cash Consideration by (y) the Parent Share Price and (B) the Exchange Ratio.
Footnote F7
(Continued from footnote 6) Each stock option of JHX is subject to the same terms and conditions as were applicable to such Company Stock Option immediately prior to the Effective Time, including the vesting schedule.